Manrochem, the Yorkshire based international process engineering specialist, has yesterday (31 January) completed an MBO for an undisclosed sum, assisted by a team of Yorkshire advisers.
The management team comprising Edward Jennings, Business Director; David Wakefield, Technical Director; and Andrew Pearson, Engineering Director, have been collectively involved in Manrochem Limited for over 30 years. With skills based in process engineering, the business delivers specialist design, build and commission projects across the chemical, pharmaceutical, food and allied industries.
Established in 1990, Manrochem employs 20 people in the UK at its Huddersfield headquarters and also has a subsidiary company in Chennai in India. It has a blue chip client base including companies such as Syngenta, Lubrizol, Glaxo Smith Kline, 3M Healthcare, Rhodia UK Limited, Thornton & Ross, Finlay and Deltech.
The management team was advised by Rachel Neems and Maxine Burton of Leeds law firm Clarion with Richard Bright and Mike Brown of Murray Harcourt in Harrogate providing financial advice for the transaction.
Director Edward Jennings said:
Having established Manrochem’s reputation as a dynamic and well-regarded international process design company, this acquisition marks another key milestone in the development of the business. With an experienced management team at the helm, we will be able to build on the company’s success, ensuring its future.
We work in a rapidly-changing world and our ability to respond swiftly to meet new challenges is greatly appreciated by our clients. We are excited by the prospect of extending our skills and expertise to a wider client base as we move forward.
Director Andrew Pearson commented:
We have a loyal, dedicated and highly qualified workforce, the majority of whom have been with the company for many years; we are confident that with their enthusiasm and support, the new regime will go from strength to strength.